• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

多巴胺 D3 受体拮抗剂揭示了胺能 GPCR 中的一个隐匿口袋。

Dopamine D3 receptor antagonist reveals a cryptic pocket in aminergic GPCRs.

机构信息

Computational Biophysics Laboratory (GRIB-IMIM), Universitat Pompeu Fabra, Barcelona Biomedical Research Park (PRBB), Doctor Aiguader 88, 08003, Barcelona, Spain.

Acellera, PRBB, Doctor Aiguader 88, 08003, Barcelona, Spain.

出版信息

Sci Rep. 2018 Jan 17;8(1):897. doi: 10.1038/s41598-018-19345-7.

DOI:10.1038/s41598-018-19345-7
PMID:29343833
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5772633/
Abstract

The recent increase in the number of X-ray crystal structures of G-protein coupled receptors (GPCRs) has been enabling for structure-based drug design (SBDD) efforts. These structures have revealed that GPCRs are highly dynamic macromolecules whose function is dependent on their intrinsic flexibility. Unfortunately, the use of static structures to understand ligand binding can potentially be misleading, especially in systems with an inherently high degree of conformational flexibility. Here, we show that docking a set of dopamine D3 receptor compounds into the existing eticlopride-bound dopamine D3 receptor (D3R) X-ray crystal structure resulted in poses that were not consistent with results obtained from site-directed mutagenesis experiments. We overcame the limitations of static docking by using large-scale high-throughput molecular dynamics (MD) simulations and Markov state models (MSMs) to determine an alternative pose consistent with the mutation data. The new pose maintains critical interactions observed in the D3R/eticlopride X-ray crystal structure and suggests that a cryptic pocket forms due to the shift of a highly conserved residue, F. Our study highlights the importance of GPCR dynamics to understand ligand binding and provides new opportunities for drug discovery.

摘要

近年来,G 蛋白偶联受体(GPCR)的 X 射线晶体结构数量不断增加,这使得基于结构的药物设计(SBDD)成为可能。这些结构表明,GPCR 是高度动态的大分子,其功能依赖于其固有灵活性。不幸的是,使用静态结构来理解配体结合可能会产生误导,特别是在固有构象灵活性较高的系统中。在这里,我们表明,将一组多巴胺 D3 受体化合物对接入现有的依替唑仑结合的多巴胺 D3 受体(D3R)X 射线晶体结构中,得到的构象与通过定点突变实验获得的结果不一致。我们通过使用大规模高通量分子动力学(MD)模拟和马尔可夫状态模型(MSM)来克服静态对接的局限性,确定了与突变数据一致的替代构象。新构象保持了在 D3R/依替唑仑 X 射线晶体结构中观察到的关键相互作用,并表明由于高度保守的残基 F 的移位,形成了一个隐匿口袋。我们的研究强调了 GPCR 动力学对理解配体结合的重要性,并为药物发现提供了新的机会。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a20e/5772633/c0cf66ce13d6/41598_2018_19345_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a20e/5772633/bb3bb61b0e65/41598_2018_19345_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a20e/5772633/801777b4e274/41598_2018_19345_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a20e/5772633/9eb976bc255e/41598_2018_19345_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a20e/5772633/9f677c008dc9/41598_2018_19345_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a20e/5772633/c0cf66ce13d6/41598_2018_19345_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a20e/5772633/bb3bb61b0e65/41598_2018_19345_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a20e/5772633/801777b4e274/41598_2018_19345_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a20e/5772633/9eb976bc255e/41598_2018_19345_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a20e/5772633/9f677c008dc9/41598_2018_19345_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a20e/5772633/c0cf66ce13d6/41598_2018_19345_Fig5_HTML.jpg

相似文献

1
Dopamine D3 receptor antagonist reveals a cryptic pocket in aminergic GPCRs.多巴胺 D3 受体拮抗剂揭示了胺能 GPCR 中的一个隐匿口袋。
Sci Rep. 2018 Jan 17;8(1):897. doi: 10.1038/s41598-018-19345-7.
2
Distinct inactive conformations of the dopamine D2 and D3 receptors correspond to different extents of inverse agonism.多巴胺 D2 和 D3 受体的不同非活性构象对应于不同程度的反向激动作用。
Elife. 2020 Jan 27;9:e52189. doi: 10.7554/eLife.52189.
3
Structure of the human dopamine D3 receptor in complex with a D2/D3 selective antagonist.人源多巴胺 D3 受体与 D2/D3 选择性拮抗剂复合物的结构。
Science. 2010 Nov 19;330(6007):1091-5. doi: 10.1126/science.1197410.
4
The impact of molecular dynamics sampling on the performance of virtual screening against GPCRs.分子动力学采样对 GPCR 虚拟筛选性能的影响。
J Chem Inf Model. 2013 Nov 25;53(11):2990-9. doi: 10.1021/ci400087b. Epub 2013 Oct 31.
5
Improving virtual screening of G protein-coupled receptors via ligand-directed modeling.通过配体导向建模改进G蛋白偶联受体的虚拟筛选
PLoS Comput Biol. 2017 Nov 13;13(11):e1005819. doi: 10.1371/journal.pcbi.1005819. eCollection 2017 Nov.
6
Towards predictive docking at aminergic G-protein coupled receptors.迈向胺能G蛋白偶联受体的预测性对接
J Mol Model. 2015 Nov;21(11):284. doi: 10.1007/s00894-015-2824-9. Epub 2015 Oct 9.
7
Reliability of Docking-Based Virtual Screening for GPCR Ligands with Homology Modeled Structures: A Case Study of the Angiotensin II Type I Receptor.基于对接的虚拟筛选技术用于 G 蛋白偶联受体配体的可靠性研究:以血管紧张素 II 型 1 型受体为例。
ACS Chem Neurosci. 2019 Jan 16;10(1):677-689. doi: 10.1021/acschemneuro.8b00489. Epub 2018 Oct 17.
8
Efficiency of Homology Modeling Assisted Molecular Docking in G-protein Coupled Receptors.同源建模辅助分子对接在 G 蛋白偶联受体中的效率。
Curr Top Med Chem. 2021;21(4):269-294. doi: 10.2174/1568026620666200908165250.
9
Antipsychotic haloperidol binding to the human dopamine D3 receptor: beyond docking through QM/MM refinement toward the design of improved schizophrenia medicines.抗精神病药氟哌啶醇与人多巴胺 D3 受体的结合:超越对接——通过 QM/MM 精修设计改良的精神分裂症药物。
ACS Chem Neurosci. 2014 Oct 15;5(10):1041-54. doi: 10.1021/cn500111e. Epub 2014 Sep 18.
10
Multi-target dopamine D3 receptor modulators: Actionable knowledge for drug design from molecular dynamics and machine learning.多靶点多巴胺 D3 受体调节剂:来自分子动力学和机器学习的药物设计可操作知识。
Eur J Med Chem. 2020 Feb 15;188:111975. doi: 10.1016/j.ejmech.2019.111975. Epub 2019 Dec 23.

引用本文的文献

1
Molecular basis of ligand binding and receptor activation at the human A adenosine receptor.人类A1腺苷受体配体结合及受体激活的分子基础
Nat Commun. 2025 Aug 18;16(1):7674. doi: 10.1038/s41467-025-62872-x.
2
Recent computational advances in the identification of cryptic binding sites for drug discovery.药物发现中隐秘结合位点识别的近期计算进展。
Bioinform Adv. 2025 Jul 1;5(1):vbaf156. doi: 10.1093/bioadv/vbaf156. eCollection 2025.
3
Multiple recent HCAR2 structures demonstrate a highly dynamic ligand binding and G protein activation mode.

本文引用的文献

1
Trends in GPCR drug discovery: new agents, targets and indications.G蛋白偶联受体(GPCR)药物研发趋势:新药物、靶点与适应症
Nat Rev Drug Discov. 2017 Dec;16(12):829-842. doi: 10.1038/nrd.2017.178. Epub 2017 Oct 27.
2
D dopamine receptor high-resolution structures enable the discovery of selective agonists.D 多巴胺受体的高分辨率结构有助于发现选择性激动剂。
Science. 2017 Oct 20;358(6361):381-386. doi: 10.1126/science.aan5468.
3
Activation-Induced Conformational Changes of Dopamine D3 Receptor Promote the Formation of the Internal Water Channel.
多个最近的 HCAR2 结构展示了一个高度动态的配体结合和 G 蛋白激活模式。
Nat Commun. 2024 Jun 25;15(1):5364. doi: 10.1038/s41467-024-49536-y.
4
Bioorthogonal Tethering Enhances Drug Fragment Affinity for G Protein-Coupled Receptors in Live Cells.生物正交连接增强了药物片段在活细胞中与 G 蛋白偶联受体的亲和力。
J Am Chem Soc. 2023 May 24;145(20):11173-11184. doi: 10.1021/jacs.3c00972. Epub 2023 Apr 28.
5
Activation mechanism of the human Smoothened receptor.人类 Smoothened 受体的激活机制。
Biophys J. 2023 Apr 4;122(7):1400-1413. doi: 10.1016/j.bpj.2023.03.007. Epub 2023 Mar 6.
6
Mind the Gap-Deciphering GPCR Pharmacology Using 3D Pharmacophores and Artificial Intelligence.关注差距——利用三维药效团和人工智能解析GPCR药理学
Pharmaceuticals (Basel). 2022 Oct 22;15(11):1304. doi: 10.3390/ph15111304.
7
Approach to the specificity and selectivity between D2 and D3 receptors by mutagenesis and binding experiments part I: Expression and characterization of D2 and D3 receptor mutants.基于诱变和结合实验的 D2 和 D3 受体特异性和选择性研究方法 第一部分:D2 和 D3 受体突变体的表达和特性。
Protein Sci. 2022 Dec;31(12):e4459. doi: 10.1002/pro.4459.
8
Potential Mechanisms for Why Not All Antipsychotics Are Able to Occupy Dopamine D Receptors in the Brain .为何并非所有抗精神病药物都能占据大脑中的多巴胺D受体的潜在机制。
Front Psychiatry. 2022 Mar 24;13:785592. doi: 10.3389/fpsyt.2022.785592. eCollection 2022.
9
The Impact of the Secondary Binding Pocket on the Pharmacology of Class A GPCRs.二级结合口袋对A类G蛋白偶联受体药理学的影响
Front Pharmacol. 2022 Mar 9;13:847788. doi: 10.3389/fphar.2022.847788. eCollection 2022.
10
Evidence for Two Modes of Binding of the Negative Allosteric Modulator SB269,652 to the Dopamine D Receptor.负变构调节剂SB269,652与多巴胺D受体结合的两种模式的证据。
Biomedicines. 2021 Dec 23;10(1):22. doi: 10.3390/biomedicines10010022.
多巴胺 D3 受体的激活诱导构象变化促进内部水通道的形成。
Sci Rep. 2017 Oct 6;7(1):12792. doi: 10.1038/s41598-017-13155-z.
4
Complete protein-protein association kinetics in atomic detail revealed by molecular dynamics simulations and Markov modelling.通过分子动力学模拟和马尔可夫建模揭示原子细节的完整蛋白质-蛋白质相互作用动力学。
Nat Chem. 2017 Oct;9(10):1005-1011. doi: 10.1038/nchem.2785. Epub 2017 Jun 5.
5
Toward Understanding the Structural Basis of Partial Agonism at the Dopamine D Receptor.迈向理解多巴胺D受体部分激动作用的结构基础
J Med Chem. 2017 Jan 26;60(2):580-593. doi: 10.1021/acs.jmedchem.6b01148. Epub 2017 Jan 5.
6
Dopamine D3/D2 Receptor Antagonist PF-4363467 Attenuates Opioid Drug-Seeking Behavior without Concomitant D2 Side Effects.多巴胺 D3/D2 受体拮抗剂 PF-4363467 可减轻阿片类药物觅药行为而无 D2 受体相关副作用。
ACS Chem Neurosci. 2017 Jan 18;8(1):165-177. doi: 10.1021/acschemneuro.6b00297. Epub 2016 Oct 21.
7
GPCR Dynamics: Structures in Motion.G 蛋白偶联受体动力学:运动中的结构。
Chem Rev. 2017 Jan 11;117(1):139-155. doi: 10.1021/acs.chemrev.6b00177. Epub 2016 Sep 13.
8
Signal transmission through the CXC chemokine receptor 4 (CXCR4) transmembrane helices.通过CXC趋化因子受体4(CXCR4)跨膜螺旋进行信号传导。
Proc Natl Acad Sci U S A. 2016 Aug 30;113(35):9928-33. doi: 10.1073/pnas.1601278113. Epub 2016 Aug 19.
9
Multibody cofactor and substrate molecular recognition in the myo-inositol monophosphatase enzyme.肌醇单磷酸酶中多体辅因子与底物的分子识别
Sci Rep. 2016 Jul 21;6:30275. doi: 10.1038/srep30275.
10
GPCRdb: the G protein-coupled receptor database - an introduction.GPCRdb:G蛋白偶联受体数据库——简介
Br J Pharmacol. 2016 Jul;173(14):2195-207. doi: 10.1111/bph.13509. Epub 2016 Jun 3.